The potential use of cellular therapeutics against cardiac inflammation in heart failure patients

Back

ESC Premium Access

The potential use of cellular therapeutics against cardiac inflammation in heart failure patients

Session: Poster session 2 - Coronary artery disease: from bench to bedside

Topic: Inflammation and microcirculation

Speaker: Professor J. Sluijter (Utrecht, NL)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Joost Sluijter

University Medical Center Utrecht, Utrecht (Netherlands (The))

9 presentations

0 follower

71 more presentations in this session

Extended duration betrixaban in acutely ill medical patients is associated with reduction in fatal or irreversible ischemic or bleeding events compared with standard dose enoxaparin: an APEX substudy

Speaker: Doctor G. Chi (Boston, US)

Access

Abstract

Slides

Proprotein convertase subtilisin/kexin type 9 (PCSK9), platelet activation and risk of cardiovascular events in atrial fibrillation

Speaker: Professor P. Pignatelli Spinazzola (Rome, IT)

Access

Abstract

Slides

Factor V Leiden related risk of thromboembolic and bleeding complications in patients with established coronary heart disease.

Speaker: Doctor B. Mahmoodi (Rotterdam, NL)

Access

Abstract

Slides

Factor V Leiden and prothrombin G20210A mutations in patients with premature myocardial infarction.

Speaker: Professor L. Rallidis (Athens, GR)

Access

Abstract

Slides

Angiographic and hemodynamic modifications of Myocardial Bridge during supine bicycle exercise

Speaker: Doctor J. Adjedj (Saint Laurent du Var, FR)

Access

Abstract

Slides

Access the full session

Poster session 2 - Coronary artery disease: from bench to bedside

Speakers: Professor J. Sluijter, Doctor G. Chi, Professor P. Pignatelli Spinazzola, Doctor B. Mahmoodi, Professor L. Rallidis...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources